Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-16
1994-05-03
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514432, 514913, 549 9, 549 23, A61K 3138, C07D33300
Patent
active
053088638
ABSTRACT:
Thieno[2,3-b]thiopyran-2-sulfonamides and ring homologs with a hydrophilic substituted-alkyl group adjacent to the thiopyran sulfur are carbonic anhydrase inhibitors topically effective in lowering intraocular pressure.
REFERENCES:
patent: 4619939 (1986-10-01), Maren
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 4863922 (1989-09-01), Baldwin et al.
patent: 5045561 (1991-09-01), Baldwin et al.
patent: 5120757 (1992-06-01), Baldwin et al.
Baldwin John J.
Habecker Charles N.
Ponticello Gerald S.
Selnick Harold G.
Ayler Sylvia A.
Cintins Marianne M.
Daniel Mark R.
DiPrima Joseph F.
Kilby Scalzo Catherine S.
LandOfFree
Substituted aromatic sulfonamides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aromatic sulfonamides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aromatic sulfonamides as antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2115309